Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RAYMOND TUN

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1912085036
CMS profile
313640
Location
MT VERNON, NY

General Payments · PY2018–2024

$1,020.37

  • Reported across 55 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$325.86

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $325.86 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $117.35 5
Bayer HealthCare Pharmaceuticals Inc. $64.48 3
GlaxoSmithKline, LLC. $44.73 2
Novo Nordisk AS $37.12 2
Oyster Point Pharma, Inc. $34.22 1
Acerta Pharma LLC $27.96 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $109.63 8
PY2019 $61.37 5
PY2020 $149.26 10
PY2021 $49.10 3
PY2022 $21.35 1
PY2023 $303.80 14
PY2024 $325.86 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $28.27 01/25/2024 Food and Beverage Undisputed 01/23/2026 1117705410 CMS
Amgen Inc. $21.64 02/21/2024 Food and Beverage Undisputed 01/23/2026 1117705412 CMS
Amgen Inc. $23.81 03/28/2024 Food and Beverage Undisputed 01/23/2026 1117705414 CMS
Amgen Inc. $23.64 04/25/2024 Food and Beverage Undisputed 01/23/2026 1117705416 CMS
Amgen Inc. $19.99 08/15/2024 Food and Beverage Undisputed 01/23/2026 1117705418 CMS
AstraZeneca Pharmaceuticals LP $27.96 07/18/2024 Food and Beverage Undisputed 01/23/2026 1105723913 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.45 01/17/2024 Food and Beverage Undisputed 01/23/2026 1086135879 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.88 02/29/2024 Food and Beverage Undisputed 01/23/2026 1086128550 CMS
Bayer Healthcare Pharmaceuticals Inc. $22.15 03/14/2024 Food and Beverage Undisputed 01/23/2026 1086134500 CMS
GlaxoSmithKline, LLC. $28.27 06/13/2024 Food and Beverage Undisputed 01/23/2026 1116361295 CMS
GlaxoSmithKline, LLC. $16.46 07/30/2024 Food and Beverage Undisputed 01/23/2026 1115989482 CMS
Novo Nordisk Inc $14.41 05/22/2024 Food and Beverage Undisputed 01/23/2026 1096637082 CMS
Novo Nordisk Inc $22.71 09/06/2024 Food and Beverage Undisputed 01/23/2026 1096711033 CMS
Oyster Point Pharma, Inc. $34.22 10/01/2024 Food and Beverage Undisputed 01/23/2026 1147414230 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.